Heparin and Tocilizumab in Patients with Severe COVID-19: The HEPMAB Randomized Clinical Trial

.noscript-container { margin: 0 auto; width: 400px; text-align: center; margin-top: 150px; }

protocols.io requires JavaScript to be enabled in the browser.